Price $37.00 |
Market Cap
4.08B
|
Sector Health Care |
Div. Growth
8.90%
|
|
P/E
23.1
|
P/B
2.84
|
P/S
0.71
|
Dividend %
2.50%
|
|
P/CF
-
|
P/FCF
182.8
|
Op. Cash Flow
162.7K
|
FCF
0.2
|
|
Op. Margin
5.10%
|
Net Margin
3.10%
|
ROE
12.20%
|
ROI
8.50%
|
|
ROA
4.80%
|
EPS Growth
-6.90%
|
Current Ratio
2.0
|
Debt/Equity
71.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Vycor Medical Inc (VYCO) | $0.30 | - | - | 3.8M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.59 | - | - | 4.8M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.23 | - | - | 31.1M | Strong Buy |
| iCAD Inc (ICAD) | $3.36 | - | - | 64.7M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.39 | - | - | 17.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
